OKYO Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for OKYO Pharma (OKYO).

Price Target Range — 10 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$6Upside to Avg. PT+310.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 13, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$7→$5
Feb 20, 2026	Piper Sandler	Biren Amin	Initiate	Overweight	$7
Dec 8, 2025	B. Riley Securities	William Woods	Initiate	Buy	$5
Sep 23, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$7
May 5, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$7
Feb 18, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$7
Feb 14, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$7
Feb 10, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$7
Oct 24, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$7
Oct 16, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$7
Aug 27, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$7
Jul 12, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$7
Jul 11, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$7
Mar 22, 2024	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$6→$7
Jan 8, 2024	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$4→$5
Dec 5, 2023	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$4
Nov 2, 2023	HC Wainwright & Co.	Yi Chen	Initiate	Buy	$4

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on OKYO Pharma, Lowers Price Target to $5

HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and lowers the price target from $7 to $5.

Benzinga Newsdesk

This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

PRO
Piper Sandler Initiates Coverage On OKYO Pharma with Overweight Rating, Announces Price Target of $7

Piper Sandler analyst Biren Amin initiates coverage on OKYO Pharma (NASDAQ:OKYO) with a Overweight rating and announces Price Target of $7.

Benzinga Newsdesk

PRO
B. Riley Securities Initiates Coverage On OKYO Pharma with Buy Rating, Announces Price Target of $5

B. Riley Securities analyst William Woods initiates coverage on OKYO Pharma (NASDAQ:OKYO) with a Buy rating and announces Price Target of $5.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates OKYO Pharma (NASDAQ:OKYO) with a Buy and maintains $7 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates OKYO Pharma (NASDAQ:OKYO) with a Buy and maintains $7 price target.

Benzinga Newsdesk

OKYO Pharma Ltd

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

OKYO Pharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on OKYO Pharma, Lowers Price Target to $5

This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday

PRO
Piper Sandler Initiates Coverage On OKYO Pharma with Overweight Rating, Announces Price Target of $7

PRO
B. Riley Securities Initiates Coverage On OKYO Pharma with Buy Rating, Announces Price Target of $5

PRO
HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

People Also Watch

People Also Watch

OKYO Pharma Ltd

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

OKYO Pharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on OKYO Pharma, Lowers Price Target to $5

This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday

PROPiper Sandler Initiates Coverage On OKYO Pharma with Overweight Rating, Announces Price Target of $7

PROB. Riley Securities Initiates Coverage On OKYO Pharma with Buy Rating, Announces Price Target of $5

PROHC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

PROHC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on OKYO Pharma, Lowers Price Target to $5

PRO
Piper Sandler Initiates Coverage On OKYO Pharma with Overweight Rating, Announces Price Target of $7

PRO
B. Riley Securities Initiates Coverage On OKYO Pharma with Buy Rating, Announces Price Target of $5

PRO
HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target